文献速递关节外科

糖尿病对医保受益者择期全关节置换术后90天诊疗事件的影响

Impact of Diabetes on 90-Day Episodes of Care After Elective Total Joint Arthroplasty Among Medicare Beneficiaries.
PubMed 文献 · J Bone Joint Surg Am · 2020-01-01

基于2013至2014年医保数据,分析择期全膝或全髋关节置换术后的并发症与再入院风险。结果显示,所有糖尿病组的再入院风险均显著升高;未控制糖尿病组的全膝置换并发症和再入院风险最高,控制但伴并发症的糖尿病组全髋置换并发症和再入院风险最高。作者认为应考虑将糖尿病及其相关全身并发症纳入关节置换替代支付模型的风险调整。

要点

  • 所有糖尿病组的再入院风险均显著高于无糖尿病组。
  • 未控制糖尿病组全膝置换的并发症与再入院风险最高。
  • 控制但伴并发症的糖尿病组全髋置换的并发症与再入院风险最高。

核心结论

  • 所有糖尿病类别的再入院风险均升高。
  • 未控制糖尿病组的全膝置换再入院与并发症风险最高。
  • 控制但伴并发症的糖尿病组的全髋置换再入院与并发症风险最高。
  • 作者认为应考虑在关节置换替代支付模型的费用调整中纳入糖尿病及相关全身并发症。

研究设计与样本

  • 研究从2013年和2014年医保文件中提取并发症(n=521,230)和再入院(n=515,691)数据。
  • 采用ICD-9编码将糖尿病状态分为无糖尿病、控制且无并发症、控制但伴并发症和未控制四组。
  • 使用逻辑回归估计不同糖尿病状态下的全膝或全髋置换并发症与再入院比值比,并调整社会人口学和临床特征(包括合并症)。
  • 证据等级为预后III级。

主要发现

  • 与无糖尿病相比,未控制糖尿病组全膝置换并发症的比值比显著更高(OR 1.29,95%CI 1.06至1.57)。
  • 与无糖尿病相比,控制但伴并发症糖尿病组全髋置换并发症的比值比显著更高(OR 1.45,95%CI 1.17至1.80)。
  • 与无糖尿病相比,所有糖尿病组的再入院比值比均显著更高(全膝置换OR 1.21至1.48,全髋置换OR 1.20至1.70)。

关键数值与推荐

  • 全膝置换并发症:未控制糖尿病组相较于无糖尿病组OR 1.29(95%CI 1.06至1.57)。
  • 全髋置换并发症:控制但伴并发症糖尿病组相较于无糖尿病组OR 1.45(95%CI 1.17至1.80)。
  • 全膝置换再入院:所有糖尿病组相较于无糖尿病组OR 1.21至1.48。
  • 全髋置换再入院:所有糖尿病组相较于无糖尿病组OR 1.20至1.70。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: In an effort to improve quality and reduce costs, reimbursement for total knee arthroplasty (TKA) and total hip arthroplasty (THA) in the United States is being based on the value of care provided, with adjustments for some qualifying comorbidities, including diabetes in its most severe form and excluding many diabetes codes. The aims of this study were to examine the effects of diabetes on elective TKA or THA complications and readmission risks among Medicare beneficiaries. METHODS: Complication (n = 521,230) and readmission (n = 515,691) data were extracted from Medicare files in 2013 and 2014. Diabetes status (no diabetes, controlled-uncomplicated diabetes, controlled-complicated diabetes, and uncontrolled diabetes) was identified with ICD-9 (International Classification of Diseases, 9th Revision) codes. TKA or THA complications and readmission odds based on diabetes status were estimated using logistic regression and adjusted for sociodemographic and clinical characteristics, including comorbidities. RESULTS: Compared with no diabetes, the odds ratio (OR) of TKA complications was significantly higher for uncontrolled diabetes (1.29, 95% confidence interval [CI] = 1.06 to 1.57). The OR of THA complications was significantly higher for controlled-complicated diabetes (1.45, 95% CI = 1.17 to 1.80). The OR of readmission was significantly higher for all diabetes groups (1.21 to 1.48 for TKA, 1.20 to 1.70 for THA). CONCLUSIONS: Readmission odds were higher in all diabetes categories. The uncontrolled-diabetes group had the greatest TKA readmission and complication odds. The controlled-complicated diabetes group had the greatest THA readmission and complication odds. The findings suggest that including diabetes and associated systemic complications in cost adjustments in alternative payment models for arthroplasty should be considered. LEVEL OF EVIDENCE: Prognostic Level III. See Instructions for Authors for a complete description of levels of evidence.

来源:J Bone Joint Surg Am,查看原文。版权归原作者所有。

引用

  1. Na A, Middleton A, Haas A, et al. Impact of Diabetes on 90-Day Episodes of Care After Elective Total Joint Arthroplasty Among Medicare Beneficiaries. J Bone Joint Surg Am. 2020. PMID: 33093299. doi:10.2106/JBJS.20.00203

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。